Indium (111In) satumomab pendetide: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
No edit summary Tag: Manual revert |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 75: | Line 75: | ||
{{antineoplastic-drug-stub}} | {{antineoplastic-drug-stub}} | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | |||
Latest revision as of 12:52, 18 March 2025
| Indium (111In) satumomab pendetide | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | none |
| KEGG | |
Indium (111In) satumomab pendetide (trade name OncoScint CR103) is a mouse monoclonal antibody which is used for cancer diagnosis.<ref>,
Usefulness of scintigraphy images with 111In-CYT-103 in the diagnosis of colonic and rectal recurrence, Gaceta Médica de México, 2002, Vol. 138(Issue: 2), pp. 139–144, PMID: 12001423,</ref> The antibody, satumomab, is linked to pendetide, a derivative of DTPA. Pendetide acts as a chelating agent for the radionuclide indium-111.
References[edit]
<references group="" responsive="1"></references>
External links[edit]
| Diagnostic radiopharmaceuticals (V09) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
This article is a monoclonal antibody–related stub. You can help WikiMD by expanding it!
